Kyprolis 60 mg (Carfilzomib POWDER FOR SOLUTION) 60 MG

KYPROLIS 60 MG is a powder for solution used in intravenous therapy. This medication is designed to support specific therapeutic needs, often discussed with healthcare providers.

Strength

60 MG

Manufacturer / TM Owner

AMGEN CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KYPROLIS 60 MG is primarily used in the management of certain conditions that require targeted treatment. It is often prescribed for conditions that involve abnormal cell growth, and its use is typically determined by a healthcare professional based on individual patient needs. The medication is administered intravenously, making it suitable for in-clinic or hospital settings.

Side Effects

Common effects of KYPROLIS 60 MG may include fatigue, nausea, and changes in blood pressure. Some individuals may experience temporary discomfort at the injection site. These effects can vary widely among users, and it is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

KYPROLIS 60 MG should be handled with care, ensuring proper storage and preparation. It is crucial to follow the instructions provided by healthcare professionals to minimize the risk of adverse reactions. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

KYPROLIS 60 MG may interact with certain medications, including those that affect the liver or immune system. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol and other substances should be discussed with a healthcare professional to ensure safe use.

Frequently Asked Questions

KYPROLIS 60 MG is used in the management of certain conditions involving abnormal cell growth, as determined by a healthcare provider.

KYPROLIS 60 MG is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common effects may include fatigue, nausea, and changes in blood pressure. Some individuals may experience discomfort at the injection site.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safe use.

Patients should follow the instructions provided by their healthcare provider, including proper storage and preparation, to minimize the risk of adverse reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.